Dr. Hermann Mucke, H.M. Pharma Consultancy's founder and principal, has been invited to speak at two premier industry meetings in early 2007: Cambridge Healthtech Institute's 3rd Preclinical Development conference and IBC's inaugural conference, "From Discovery to IND." Dr. Mucke's talks will address clinical microdosing and other issues raised by FDA's Exploratory IND Guideline.

The CHI meeting, which is Track #4 of the 14th International Molecular Medicine Tri-Conference (www.tri-conference.com), will take place from February 28 - March 2, 2007 at the Moscone North Convention Center in San Francisco. The IBC meeting is scheduled for March 13-14, 2007 at the Sheraton Inner Harbor Hotel in Baltimore; details will be made available at www.ibclifesciences.com.

"This shows how our written reports and webcasts on the streamlining of the clinical trial process have resonated with industry players," said Dr. Mucke. "We are profoundly grateful for these invitations. They give us the opportunity to further advance our ideas in direct personal interaction with hundreds of highly reputed executives and scientists."